Navigation Links
Novo Nordisk Partners with Minneapolis Community Groups to Support Diabetes Education Programs
Date:8/31/2011

MINNEAPOLIS, Aug. 31, 2011 /PRNewswire/ -- This evening, Novo Nordisk awarded sponsorships totaling $100,000 to 4 Minneapolis-based community organizations to support programs that educate people living with type 2 diabetes on how to better manage their diabetes and reduce the risk of long-term diabetes related complications. The sponsorships are part of the Novo Nordisk Community Care program, which aims to promote enduring, sustainable change for people living with diabetes. The groups receiving sponsorships tonight represent diverse communities in Minneapolis and are working diligently to help improve patients' lives.

The Minneapolis organizations that received program sponsorships include:

  • American Diabetes Association, Minneapolis-St. Paul Region: to sponsor the "Pathways to Better Health" Program kicking off at the October 15 Diabetes EXPO
  • A Partnership of Diabetics (A-POD): to educate Phillips Community residents with type 2 diabetes about self-management strategies and provide weekly "Meet-Up" support groups
  • HealthEast Foundation: to support their partnership with the St. Paul YMCA and St. Paul Diabetes Lion's Club program providing type 2 diabetes education to the uninsured population
  • Open Cities Health Center: to support their "AccessPlus" program which provides comprehensive type 2 diabetes education, screening and health services to multicultural populations

"Novo Nordisk is proud to support these community programs because they have the potential to help stem the tide of diabetes in Minneapolis," said Lori Moore, Executive Director of Communications and Public Affairs at Novo Nordisk. "Novo Nordisk brings innovative treatments and devices to the diabetes community, but as an industry leader, we also have the opportunity and responsibility to provide resources to local organizations whose deep understanding of their constituency's needs can make a significant impact on the way patients manage their disease. We very much look forward to seeing the programs roll out and make a difference in the communities they serve."

Novo Nordisk will work with each group to create and promote programs that use a variety of hands-on education and intervention techniques to reach diabetes patients in Minneapolis. According to a recent study commissioned by Novo Nordisk and conducted by the Institute for Alternative Futures, in 2010, over 198,000 Minneapolis residents (6%) had diagnosed or undiagnosed diabetes and 11.8% (23,270) of those had serious complications, such as visual impairment, renal failure, and leg amputation. The annual cost to the residents of Minneapolis for diabetes was $2 billion in 2010. Further, forecasts project that by 2025, more than 413,000 Minneapolis residents will have diabetes at a total cost of $4.1 billion. Statewide, nearly 10.4% of Minnesota residents are projected to have diabetes by 2025 at a cost of $6.4 billion.

In 2011, sponsorships have already been awarded in Philadelphia and will also be awarded in Atlanta and Boston to inspire similar grassroots education programs. For more information about Novo Nordisk Community Care and to find local event listings and resources for people living with diabetes, go to NovoNordiskCommunityCare.com.

About Novo Nordisk

Headquartered in Denmark, Novo Nordisk is a global healthcare company with more than 88 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy and hormone replacement therapy. For more information, visit novonordisk-us.com.


'/>"/>
SOURCE Novo Nordisk
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Novo Nordisk and Partnership of Ivy Equities, LCOR and Intercontinental RE Corp. Announce Lease Agreement for N.J. Pharmaceutical Companys New U.S. Headquarters
2. Novo Nordisk A/S: PharmaVitae Profile
3. Video from Novo Nordisk A/S available on thenewsmarket.com: Novo Nordisk Receives Approval for Victoza in China
4. Novo Nordisk Submits First Recombinant Treatment for Factor XIII Deficiency for U.S. Regulatory Approval
5. Novo Nordisk Creates First Mobile Application to Help Doctors Diagnose Bleeding Disorders
6. Novo Nordisk Intends to Appeal Adverse Ruling in Prandin® (repaglinide) Patent Case
7. Reportlinker Adds Novo Nordisk A/S: PharmaVitae Profile
8. Novo Nordisk A/S and Emisphere Technologies, Inc. Announce License Agreement to Develop Oral Formulation of Insulin for Diabetes
9. Novo Nordisk and Chip Ganassi Racing Team Up for 2011 IZOD IndyCar Series
10. Novo Nordisk and Entertainment Industries Council Work Together to Improve Public Education and Awareness about Diabetes Epidemic
11. Novo Nordisk to Invest $73m in Expansion of U.S. Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... TapImmune,Inc. (TPIV), a clinical-stage immune-oncology company ... and vaccines for the treatment of cancer & metastatic disease, ... Growth Capital Expo to be held on May 3 ... in Las Vegas, Nevada.  The Company presentation will be ... by Dr. John N. Bonfiglio a TapImmune Board ...
(Date:4/27/2016)... MARLBOROUGH, Mass., April 27, 2016  Hologic, Inc. ... Company,s financial results for the fiscal second quarter ... share (EPS) of $0.24 increased 41.2%, and non-GAAP ... $693.3 million increased 5.8% on a reported basis, ... "We posted another good quarter, highlighted ...
(Date:4/27/2016)... , le 27 Avril 2016 ... d,affaires a progressé de +5% sur le trimestre, ... récurrentes de consommables  Croissance de +16% ... Mauna Kea Technologies (Euronext : MKEA, ... d,endomicroscopie confocale laser, annonce aujourd,hui son chiffre d,affaires ...
Breaking Medicine Technology:
(Date:5/2/2016)... ... May 02, 2016 , ... This week Omega Institute, a ... guest season which runs through October. Omega is offering a record 370 in-person workshops ... “There has never been such widespread interest in or need for the knowledge and ...
(Date:5/2/2016)... ... 02, 2016 , ... Dr. Rassouli, dentist in Orange County, CA ... the research, which was published in the “Journal of the American Geriatrics Society,” more ... million Americans have Alzheimer’s disease. The study found that dental problems may increase the ...
(Date:5/2/2016)... RICHEY, Fla. (PRWEB) , ... ... ... and medical researchers report that many commonly used prescription medications, including anxiolytics, ... (1). To mitigate these risks, Novus Medical Detox Center —a leading ...
(Date:5/2/2016)... , ... May 02, 2016 , ... ... (AAC) event, will be held at the Bellagio Hotel in Las Vegas, NV ... Social Work (NASW) will be co-hosting the event. , This year’s conference will ...
(Date:5/2/2016)... ... May 02, 2016 , ... Consultative health care market research ... Callandrillo and Duane Reed, VP of business development of AJMC Strategic Solutions, will ... Group (PBIRG) General Meeting from May 15-17 at the Boca Raton Resort ...
Breaking Medicine News(10 mins):